CLPT ClearPoint Neuro Inc.

Building on the imaging power of MRI, ClearPoint Neuro is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The company's ClearPoint® system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing MRI suite to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, ClearPoint Neuro is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

$13.76  +0.10 (0.70%)
As of 11/30/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  07/13/2000
Outstanding shares:  23,639,616
Average volume:  305,450
Market cap:   $326,935,889
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    18507C103
ISIN:        US18507C1036
Sedol:      BKT1TK6
Valuation   (See tab for details)
PE ratio:   -27.27
PB ratio:   7.08
PS ratio:   20.78
Return on equity:   -26.84%
Net income %:   -75.27%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy